1mg, best e pharmacy in India


MRP: Rs. 469.66 for 1 strip(s) (10 tablets each)
Unfortunately, we don't have any more items in stock
Report Error

Composition for DILSAVE

Dronedarone(4 mg)

food interaction for DILSAVE

alcohol interaction for DILSAVE

pregnancy interaction for DILSAVE

lactation interaction for DILSAVE

It is better to take Dilsave 4mg tablet with food.
Interaction with alcohol is unknown. Please consult your doctor.
Dilsave 4mg tablet is highly unsafe in women who are or may become pregnant.
Human and animal studies have shown significant adverse effects on the fetus and should not be given under any circumstances. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.


Dronedarone(4 mg)


Dilsave 4mg tablet is used for treatment of irregular rhythm of heartbeats (paroxysmal or persistent atrial fibrillation or atrial flutter) and to prevent recurrence of the problem and hospitalization for irregular heartbeats (arrhythmias).

How it works

Dilsave 4mg tablet belongs to a class of medications called anti-arrhythmics. It is known to work by blocking multiple ion channels (potassium, calcium and sodium) thereby restoring normal rhythm of heartbeats.

Common side effects

Nausea, Qtc interval prolonged, Abdominal pain, Abnormal liver function tests, Bradycardia, Congestive cardiac failure, Diarrhoea, Increased creatinine level in blood, Indigestion, Itching, Rash, Vomiting, Weakness, Fatigue


No substitutes found

Top General Physicians

  • Dr. Balbir Singh
    MBBS, MD, DM, Fellowship, Fellowship
  • Dr. (Col.) Balbir Kalra
    MBBS, MD, DM
  • Dr. Sanjeev Choudhary
    MBBS, MD, DM, DNB, Fellowship
  • Dr. R. R. Kasliwal
    MBBS, MD, DM, Fellowship
  • Dr. Tapan Ghose
    MBBS, DNB, MD, DNB, Fellowship, Fellowship

Expert advice for DILSAVE

  • Contact your doctor immediately if you experience signs of heart failure such as weight gain, swelling in lower parts of the body (dependent edema), increasing breathlessness (dyspnea) while on dronedarone treatment.
  • You must take treatment for potassium and magnesium deficiencies (hypokalemia and hypomagnesemia) before starting treatment with dronedarone.
  • You may be monitored with blood creatinine tests as its level may rise during dronedarone treatment.
  • Use dronedarone with caution if you have heart diseases (e.g. coronary artery disease) or are an elderly patient (?75 years) with multiple complications.
  • You must be regularly examined for heart, liver, kidney and lung functions during treatment with dronedarone.
  • Take precautions to avoid pregnancy while on dronedarone treatment and consult your doctor immediately if you get to know that you are pregnant.
  • Use of dronedarone  is not recommended in children aged below 18 years.

Frequently asked questions for DILSAVE


Q. Is dronedarone safe?
Dronedarone is relatively safe if used at prescribed doses for the prescribed duration as advised by your doctor.
Q. Is dronedarone a beta blocker?
Dronedarone is an antiarrhythmic medication that blocks multiple ion channels. It is not a beta blocker; however it is known to have indirect inhibitory effect on beta receptors.
Q. How is dronedarone excreted?
After oral administration of dronedarone, it is excreted in its changed form (metabolites) in the feces and urine.
Q. Does dronedarone lower blood pressure?
Yes. Dronedarone has known effects on lowering blood pressure.
Q. How does dronedarone differ from amiodarone?
Dronedarone and amiodarone are both antiarrhythmic medications. They have similar uses but are prescribed for different cases of heart beat rhythm irregularities. 
Q. What is dronedarone hydrochloride?
Dronedarone hydrochloride is an anti-arrhythmic medication.

Q. What is it used for?
Used for treatment of irregular rhythm of heartbeats (paroxysmal or persistent atrial fibrillation or atrial flutter) and to prevent recurrence of the problem and hospitalization for irregular heartbeats (arrhythmias).

Q. Does it work?
  The effectiveness of dronedarone may vary upon individual response.


Content on this page was last updated on 26 November, 2014, by Dr. Varun Gupta (MD Pharmacology)